Amneal gets FDA approval for memantine/donepezil extended-release capsules
Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...
Medscape7d
Memantine: A Treatment for Alzheimer's Disease With a New Formulation
The recommended target dose is 10 mg twice daily. The US FDA recently approved an extended-release (ER) formulation of memantine for once-daily 28-mg dosing. Memantine ER was evaluated in a 24 ...
Pharm Exec5d
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Monthly Prescribing Reference11y
Namenda Xr
Memantine HCl 7mg, 14mg, 21mg, 28mg; ext-rel caps. Tabs—60; Titration Pak (28 x 5mg + 21 x 10mg)—1; Oral soln—contact supplier; XR caps 7mg, 21mg—30; 14mg, 28mg—30, 90; XR Titration Pak ...
Medscape9d
Memantine: A Treatment for Alzheimer's Disease With a New Formulation
Furthermore, the new formulation of memantine delivers a higher dose of memantine, providing a total of 28 mg instead of 20 mg daily. As a next step in determining the overall benefit brought by ...